125 related articles for article (PubMed ID: 1634912)
1. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
J Clin Oncol; 1992 Aug; 10(8):1218-24. PubMed ID: 1634912
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
[TBL] [Abstract][Full Text] [Related]
3. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.
Minsky BD; Kemeny N; Cohen AM; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
Cancer; 1991 Jun; 67(11):2859-66. PubMed ID: 2025851
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Schwartz G; Saltz L; Dougherty J; Frankel J; Wiseberg J
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):821-7. PubMed ID: 8478232
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Liaros A; Athanassiou E; Dombros N; Dervenis C; Basdanis G; Gamvros O; Souparis A; Briasoulis E; Samantas E; Kappas A; Kosmidis P; Skarlos D; Pavlidis N
Ann Oncol; 1999 Jun; 10(6):671-6. PubMed ID: 10442189
[TBL] [Abstract][Full Text] [Related]
7. Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer.
Minsky B; Cohen A; Enker W; Kelsen D; Kemeny N; Ilson D; Guillem J; Saltz L; Frankel J; Conti J
Cancer; 1994 Jan; 73(2):273-80. PubMed ID: 8293388
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
Hoff PM; Janjan N; Saad ED; Skibber J; Crane C; Lassere Y; Cleary KR; Benner S; Randolph J; Abbruzzese JL; Pazdur R
J Clin Oncol; 2000 Oct; 18(20):3529-34. PubMed ID: 11032595
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.
Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Riechman B; Saltz L; Sigurdson ER; Frankel J
Int J Radiat Oncol Biol Phys; 1992; 22(1):139-45. PubMed ID: 1727111
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer.
Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Frankel J
Cancer Invest; 1995; 13(1):1-7. PubMed ID: 7834464
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Saltz L; Frankel J
Cancer; 1993 Jun; 71(11):3486-92. PubMed ID: 8490898
[TBL] [Abstract][Full Text] [Related]
12. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
Grann A; Minsky BD; Cohen AM; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass-Loeb J
Dis Colon Rectum; 1997 May; 40(5):515-22. PubMed ID: 9152176
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
[TBL] [Abstract][Full Text] [Related]
14. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.
Bosset JF; Calais G; Daban A; Berger C; Radosevic-Jelic L; Maingon P; Bardet E; Pierart M; Briffaux A;
Eur J Cancer; 2004 Jan; 40(2):219-24. PubMed ID: 14728936
[TBL] [Abstract][Full Text] [Related]
15. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
[TBL] [Abstract][Full Text] [Related]
16. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
[TBL] [Abstract][Full Text] [Related]
17. Fluorouracil and high-dose leucovorin with radiotherapy as adjuvant therapy for rectal cancer. Results of a phase II study.
Giralt J; Rubio D; Maldonado X; Naval J; Casado S; Lara F; Roselló JM; Armengol M
Acta Oncol; 1997; 36(1):51-4. PubMed ID: 9090966
[TBL] [Abstract][Full Text] [Related]
18. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer.
Tsavaris N; Gennatas K; Kosmas C; Skopelitis HM; Gouveris P; Dimitrakopoulos A; Zacharakis M; Kouraklis G; Vasiliou J; Felekouras E; Voros D; Zografos G; Balafouta M; Paraskevaidis M; Safioleas M; Fotiadis K; Papastratis G; Karatzas G; Papalambros E
Oncol Rep; 2004 Oct; 12(4):927-32. PubMed ID: 15375524
[TBL] [Abstract][Full Text] [Related]
19. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
Cafiero F; Gipponi M; Lionetto R;
J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
